
Join to View Full Profile
5841 S Maryland Ave# MC2115Chicago, IL 60637
Phone+1 773-834-1076
Dr. Churpek is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jane Churpek is a hematologist oncologist and cancer geneticist in Madison, WI. She received her medical degree from Medical College of Wisconsin and trained at The University of Chicago. She has been in practice 12 years. She specializes in the diagnosis, including genetic testing, and management of individuals with bone marrow failure, myelodysplastic syndrome or low blood counts, especially when these run in the family. She also provides comprehensive diagnosis, early detection and prevention for individuals with hereditary cancer syndromes such as li-fraumeni syndrome, inherited bone marrow failure syndromes, hereditary breast and ovarian cancer syndrome, familial leukemia syndromes, BAP1 syndrome, and more.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2008 - 2011
University of ChicagoResidency, Internal Medicine, 2005 - 2008
Medical College of WisconsinClass of 2005
Certifications & Licensure
IL State Medical License 2008 - 2029
WI State Medical License 2019 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- Promoter TERT-Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders.Madeline Franke, Rachel Kirchner, Bianca Barredo, Amar Zaidan, Sara Torres-Esquius
American Journal of Hematology. 2026-06-15 - Germline genetic testing and privacy concerns in patients with mesothelioma.Owen D Mitchell, Abigail P Sneider, Katie Gilliam, Daniela Del Gaudio, Meghana Gaduraju
Genetics in Medicine. 2026-05-01 - Long-Read Amplicon Sequencing for the Detection of TERT Promoter Variant Clonal Hematopoiesis in Patients with Telomere Biology Disorders.Rachel E Kirchner, Miguel L Pereira, Madilynn M Peterson, Mark E Berres, Jane E Churpek
The Journal of Molecular Diagnostics. 2026-04-01
Press Mentions
Researchers Find Indicators for Breast Cancer Survivors Chance of LeukemiaDecember 8th, 2015
Researchers Focus on Risk Factors for Leukemia After Breast Cancer TreatmentDecember 7th, 2015
Characteristics That May Increase a Breast Cancer Survivor's Risk of Developing Leukemia Following Treatment IdentifiedDecember 7th, 2015
Grant Support
- Mechanisms of Parp inhibitor-induced bone marrow toxicitiesUNIVERSITY OF WISCONSIN-MADISON2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









